Parkinson's disease: World's first clinical trial for shock wave treatment

2020-09-30_news_TPS-enables-targeted-stimulation-of-cerebral-region

In 2019 the NEUROLITH® shock wave system was successfully introduced to the market. The Transcranial Pulse Stimulation (TPS®) device, which was developed by STORZ MEDICAL in Switzerland, is the only medical device marketed in Europe that is approved in the European Union for the treatment of the central nervous system of patients with Alzheimer's disease. The effect of TPS® is now being investigated in another neurological condition: In September 2020, the world's first clinical study for the treatment of Parkinson's patients with shock wave therapy using real-time documentation started at MedUni Vienna (Department of Neurology) in Austria under the direction of Professor Roland Beisteiner.

Lire la suite
0
  2409 lectures
  0 commentaires
2409 lectures
0 commentaires
Linkedin Channel Facebook Channel Instagram Channel Twitter Youtube Channel